Fresenius Kabi is a global healthcare company and subsidiary of Fresenius SE & Co. KGaA, headquartered in Bad Homburg, Germany. It specializes in medicines and technologies for infusion, transfusion, and clinical nutrition, serving hospitals and outpatient care providers worldwide.
The company’s portfolio includes sterile injectable pharmaceuticals (such as anesthetics, analgesics, anti-infectives, and oncology agents), infusion solutions, parenteral nutrition, and related medical devices including infusion pumps and disposables. Fresenius Kabi also develops and markets biosimilars for selected oncology and autoimmune indications.
Its manufacturing network spans Europe, the Americas, and Asia, with capabilities in GMP-compliant aseptic processing, sterile filling, lyophilization, and compounding, as well as packaging and distribution of ready-to-use IV medicines. Fresenius Kabi plays a significant role in hospital supply chains and critical care, with a focus on reliable production and quality standards across its global operations.